Editorial The British journal of ophthalmology. 2008 Dec;92(12):1577-80. doi: 10.1136/bjo.2008.149013 1917
Non-arteritic anterior ischaemic optic neuropathy and phosphodiesterase-5 inhibitors
非动脉炎性前部缺血性视神经病变与磷酸二酯酶-5抑制剂的关系 翻译改进
作者单位 +展开
作者单位
DOI: 10.1136/bjo.2008.149013 PMID: 19029161
摘要 中英对照阅读
Keywords:phosphodiesterase-5 inhibitors
关键词:磷酸二酯酶-5抑制剂
相关内容
-
[Central serous chorioretinopathy following the use of phosphodiesterase 5 inhibitors]
磷酸二酯酶5抑制剂的使用后中央浆液性脉络膜视网膜病变患者临床特征分析
Revue medicale de Liege. 2017 Nov;72(11):475-477.
-
Evaluation of the combination of endothelin receptor antagonists (ERA) and phosphodiesterase-5 inhibitors for the treatment of pulmonary arterial hypertension (PAH) in pathologic human pulmonary arteries in an ex-vivo organ bath model
评估内皮素受体拮抗剂与磷酸二酯酶-5抑制剂联合治疗肺动脉高压病理人类肺动脉的离体灌流模型试验效果
Pulmonary pharmacology & therapeutics. 2021 Feb:66:101985.
-
Phosphodiesterase-5 inhibitors
磷酸二酯酶-5抑制剂
Handbook of experimental pharmacology. 2013:218:229-55.
-
Oral therapies for pulmonary arterial hypertension: endothelin receptor antagonists and phosphodiesterase-5 inhibitors
肺动脉高压的口服疗法:内皮素受体拮抗剂和磷酸二酯酶-5抑制剂
Clinics in chest medicine. 2013 Dec;34(4):811-24.
-
Simultaneous quantification of endothelin receptor antagonists and phosphodiesterase 5 inhibitors currently used in pulmonary arterial hypertension
用于肺动脉高压的内皮素受体拮抗剂和磷酸二酯酶5抑制剂的现行定量方法
Journal of pharmaceutical and biomedical analysis. 2017 Sep 5:143:291-298.
-
Advances in the development of phosphodiesterase 5 inhibitors
磷酸二酯酶5抑制剂的研究进展
European journal of medicinal chemistry. 2025 Feb 6:287:117365.
-
Low intensity shockwave therapy in combination with phosphodiesterase-5 inhibitors is an effective and safe treatment option in patients with vasculogenic ED who are PDE5i non-responders: a multicenter single-arm clinical trial
低强度体外冲击波联合PDE5抑制剂治疗血管性阴茎勃起功能障碍的疗效及安全性:一项多中心单臂临床试验
International journal of impotence research. 2021 Sep;33(6):634-640.
-
Design and synthesis of pyrazolo[3,4-d]pyrimidinone derivatives: Discovery of selective phosphodiesterase-5 inhibitors
吡唑并[3,4-D]嘧啶酮衍生物的设计合成及选择性磷酸二酯酶-5抑制剂的发现
Bioorganic & medicinal chemistry letters. 2020 Aug 15;30(16):127337.